NCT03845725

Brief Summary

The aim of this study is to determine the fall and balance conditions of Parkinson's patients according to their urinary complaints.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
55

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Feb 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2018

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

February 16, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 19, 2019

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2019

Completed
Last Updated

March 10, 2020

Status Verified

March 1, 2020

Enrollment Period

1.4 years

First QC Date

February 16, 2019

Last Update Submit

March 7, 2020

Conditions

Outcome Measures

Primary Outcomes (7)

  • Unified Parkinson's Disease Rating Scale

    The UPDRS is used as a gold standard reference scale. Each item is scored using a 5-point scale, where 0 means an absence of symptoms and 4 represents the worst stage

    Baseline

  • Modified Hoehn and Yahr Stage

    The severity of PD was determined using the Modified Hoehn and Yahr Stage, which contains five stages. Stage 0: No signs of disease. Stage 1: Unilateral symptoms only. Stage 2: Bilateral symptoms. No impairment of balance. Stage 3: Balance impairment. Mild to moderate disease. Physically independent. Stage 4: Severe disability, but still able to walk or stand unassisted. Stage 5: Needing a wheelchair or bedridden unless assisted.

    Baseline

  • Berg Balance Scale

    The BBS consists of 14 items and scores range from 0 (inability to perform the task) to 4 points.

    Baseline

  • Falls-Efficacy Scale

    This scale is used to measure the perceived fear of falling. It comprises 10 questions. The score of the scale change 0-100 and the score above 70 indicates the fear of falling.

    Baseline

  • Timed Up and Go (TUG)

    The TUG is a reliable and valid measurement tool to assess functional mobility in patients with PD

    Baseline

  • International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF)

    ICIQ-SF is a short, easy-to-understand and feasible questionnaire form, which demonstrates the reliability and validity of urinary incontinence and its impact on quality of life. In ICIQ-SF questionnaire, the frequency, amount, type and effects of urinary incontinence on the daily life are questioned and scoring is performed between 0-21 values.

    Baseline

  • Overactive Bladder Version-8

    It is used for screening and diagnosis of overactive bladder. The BBS consists of 8 items. A total score of ≥8 indicates that the respondent may have an overactive bladder. The total score ranges from 0 to 40.

    Baseline

Eligibility Criteria

Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

A total of 80 patients who attended the Movement Disorders Outpatient Clinic of Ordu a University Educational Research Hospital in December 2019 and February 2020 will be evaluated.

You may qualify if:

  • Parkinson's disease according to the United Kingdom Brain Bank diagnostic criteria
  • Good cognitive functions (\>24 on Standardized Mini Mental Test)
  • volunteers who accept to participate in the study.

You may not qualify if:

  • Orthopedic and / or neurological problem affecting walking or balance skills
  • Not willing to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Movement Disorders Outpatient Clinic of Ordu a University Educational Research Hospital

Ordu, Altınordu, 52200, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Parkinson DiseaseUrinary Bladder Diseases

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Study Officials

  • Aslıhan Çatıker, Phd

    Ordu University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 16, 2019

First Posted

February 19, 2019

Study Start

February 1, 2018

Primary Completion

June 30, 2019

Study Completion

June 30, 2019

Last Updated

March 10, 2020

Record last verified: 2020-03

Data Sharing

IPD Sharing
Will not share

Locations